On April 24, the core R&D team of Harbin Pharmaceutical Group, together with Professor Wang from Hangzhou Normal University, visited our company for an inspection and technical seminar. Both parties conducted in-depth specialized exchanges focusing on cutting-edge industrial technologies, innovative product R&D, and process optimization and upgrading.
During the seminar, our company’s executives presented core insights into coenzyme electrochemical regeneration, covering reaction mechanisms, catalyst optimization, selectivity enhancement, and industrial application scenarios. Both sides thoroughly discussed existing technical bottlenecks and potential breakthrough pathways.
The visiting delegation gained a comprehensive understanding of our practical achievements in electrochemical equipment R&D and green synthesis technologies. Combined with the development trends of the pharmaceutical and fine chemical industry, all participants exchanged in-depth views and reached consensus on industry-university-research collaborative innovation, technological achievement transformation, and industrial process optimization.
This high-end technical exchange builds an efficient dialogue platform for industry-university-research cooperation and lays a solid foundation for deep collaboration between both parties in the field of coenzyme electrochemical regeneration technology. Moving forward, we will continue to deepen innovative electrochemical technologies, strengthen joint cooperation with universities and leading enterprises, and empower the high-quality development of green pharmaceutical and biomanufacturing industries through technological innovation.
